IL61175A - 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents

4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL61175A
IL61175A IL61175A IL6117580A IL61175A IL 61175 A IL61175 A IL 61175A IL 61175 A IL61175 A IL 61175A IL 6117580 A IL6117580 A IL 6117580A IL 61175 A IL61175 A IL 61175A
Authority
IL
Israel
Prior art keywords
oxadiazolin
isoquinolyl
tetrahydro
hydroxypropyl
delta
Prior art date
Application number
IL61175A
Other languages
English (en)
Other versions
IL61175A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL61175A0 publication Critical patent/IL61175A0/xx
Publication of IL61175A publication Critical patent/IL61175A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL61175A 1979-10-11 1980-09-30 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them IL61175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79CI1973A HU179951B (en) 1979-10-11 1979-10-11 Process for preparing 1,2,4-oxadiazolin-5-one derivatives and pharmaceutical compositions containing thereof

Publications (2)

Publication Number Publication Date
IL61175A0 IL61175A0 (en) 1980-11-30
IL61175A true IL61175A (en) 1984-08-31

Family

ID=10994764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61175A IL61175A (en) 1979-10-11 1980-09-30 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US4365064A (fi)
JP (1) JPS5661375A (fi)
AT (1) AT375369B (fi)
BE (1) BE885633A (fi)
CA (1) CA1154019A (fi)
CH (1) CH649547A5 (fi)
CS (1) CS241032B2 (fi)
DD (1) DD153550A5 (fi)
DE (1) DE3037432A1 (fi)
DK (1) DK149854C (fi)
ES (1) ES8106725A1 (fi)
FI (2) FI71932C (fi)
FR (1) FR2467203A1 (fi)
GB (1) GB2059967B (fi)
HU (1) HU179951B (fi)
IL (1) IL61175A (fi)
IT (1) IT1129305B (fi)
NL (1) NL8005586A (fi)
NO (1) NO154795C (fi)
PL (3) PL131451B1 (fi)
SE (1) SE452158B (fi)
SU (1) SU1087519A1 (fi)
YU (1) YU41738B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives
CA2404128C (en) * 2000-03-20 2011-01-04 Peter Literati Nagy Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
HUE040323T2 (hu) 2012-12-21 2019-02-28 Epizyme Inc PRMT5-inhibitorok és alkalmazásaik
WO2014100695A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
CA2894130A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US9611257B2 (en) 2012-12-21 2017-04-04 Epizyme, Inc. PRMT5 inhibitors and uses thereof
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
WO2016022605A1 (en) 2014-08-04 2016-02-11 Epizyme, Inc. Prmt5 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (fi) * 1967-12-07 1969-07-25
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives

Also Published As

Publication number Publication date
DK149854B (da) 1986-10-13
AT375369B (de) 1984-07-25
NO154795B (no) 1986-09-15
IT1129305B (it) 1986-06-04
DD153550A5 (de) 1982-01-13
ES495819A0 (es) 1981-09-16
NL8005586A (nl) 1981-04-14
HU179951B (en) 1983-01-28
FI803220L (fi) 1981-04-12
GB2059967B (en) 1983-06-02
ES8106725A1 (es) 1981-09-16
FR2467203B1 (fi) 1985-03-22
CA1154019A (en) 1983-09-20
PL227209A1 (fi) 1981-12-11
PL232293A1 (fi) 1982-04-26
PL232292A1 (fi) 1982-04-26
FI803219L (fi) 1981-04-12
ATA501380A (de) 1983-12-15
YU259480A (en) 1984-02-29
NO154795C (no) 1986-12-29
PL131375B1 (en) 1984-11-30
PL131451B1 (en) 1984-11-30
SU1087519A1 (ru) 1984-04-23
CS241032B2 (en) 1986-03-13
GB2059967A (en) 1981-04-29
CH649547A5 (de) 1985-05-31
BE885633A (fr) 1981-02-02
IT8068555A0 (it) 1980-10-09
JPS5661375A (en) 1981-05-26
PL132131B1 (en) 1985-02-28
IL61175A0 (en) 1980-11-30
SE452158B (sv) 1987-11-16
CS673780A2 (en) 1985-06-13
DK149854C (da) 1987-04-21
DE3037432A1 (de) 1981-05-27
FR2467203A1 (fr) 1981-04-17
DK429780A (da) 1981-04-12
SE8007025L (sv) 1981-04-12
US4365064A (en) 1982-12-21
FI71932B (fi) 1986-11-28
FI71318B (fi) 1986-09-09
FI71932C (fi) 1987-03-09
FI71318C (fi) 1986-12-19
NO803044L (no) 1981-04-13
YU41738B (en) 1987-12-31

Similar Documents

Publication Publication Date Title
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
DE3068020D1 (en) Aminoalkylbenzene derivatives, process for their preparation and pharmaceutical compositions
IL57178A0 (en) 1,3,4-triazole derivatives their preparation and pharmaceutical compositions containing them
DE3060818D1 (en) Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives, pharmaceutical compositions thereof and process for their preparation
ZA801680B (en) 2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same
DE3066434D1 (en) Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
DE3062884D1 (en) Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof
IL51339A (en) 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them
DE3067564D1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL61175A (en) 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
IL58676A (en) Histamine h2-antagonist pyrimid-4-one derivatives,their preparation and pharmaceutical compositions containing same
DE3067920D1 (en) 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
DE3070073D1 (en) 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
IL60468A (en) 4-sulfamoylphenyl-2-phenyl-imino-1,3-thiazole derivatives,process for their preparation and pharmaceutical compositions containing them
IL59719A (en) 2-(pyrid-2-yl)tetrahydrothiophene derivatives,process for their preparation and pharmaceutical compositions comprising the same
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
IL60548A (en) N-alkanesulfonyl-n-(6-methyl-ergol-8-enyl(and 8-ergolinyl)methyl)aminoethyl derivatives,their preparation and pharmaceutical compositions containing them
IL65876A (en) Heterocyclic amidoxime derivatives,their preparation and pharmaceutical compositions containing them
IL61176A0 (en) 1,2,4-oxadiazine derivatives,process for their preparation and pharmaceutical compositions containing them
DE2965906D1 (en) Oxadiazole derivatives, process for their preparation and their pharmaceutical compositions
DE2965098D1 (en) 1.2.4-triazolidine-3.5-dione derivatives, process for their preparation and pharmaceutical compositions containing them
IL73832A0 (en) 2-(1-imidazolyl)-ethanol derivatives,their preparation and pharmaceutical compositions containing them
IL61385A (en) 3-(4-(dialkylaminoalkyl)-oxy-benzoyl)-indolizine derivatives,their preparation and pharmaceutical compositions containing them